Skip to main content
Coloplast logo

Coloplast — Investor Relations & Filings

Ticker · COLO ISIN · DK0060448595 LEI · 529900NN7SOJ5QG82X67 CO Manufacturing
Open in API
Filings indexed 2,483 across all filing types
Latest filing 2020-05-11 Director's Dealing
Country DK Denmark
Listing CO COLO

About Coloplast

https://www.coloplast.com

Coloplast is a company that develops, manufactures, and markets medical devices and services for people with intimate healthcare needs. Its principal business areas include Ostomy Care, Continence Care, Interventional Urology, and Wound & Skin Care. By collaborating closely with users, the company creates solutions designed to make life easier for individuals with personal and private medical conditions. Coloplast also provides comprehensive support programs and educational resources for both patients and healthcare professionals.

Recent filings

Filing Released Lang Actions
Director's Dealing 2020
Director's Dealing Classification · 99% confidence The document title explicitly states 'Trading in Coloplast shares by board members, executives or associated persons'. This directly corresponds to the definition of Director's Dealing (insider trades). Although the text is very short and points to an attachment, the specific subject matter overrides the general 'Report Publication Announcement' rule, as the core content is about insider transactions, which is a specific mandatory disclosure type. The code DIRS (Director's Dealing) is the most appropriate classification.
2020-05-11 English
Coloplast A/S - Transactions in connection with share buy-back programme, week 19
Regulatory Filings
2020-05-11 English
Coloplast A/S - Transactions in connection with share buy-back programme, week 19
Transaction in Own Shares Classification · 100% confidence The document is a weekly update regarding Coloplast A/S's share buyback program. It details the number of shares purchased, the average price, and the total transaction value for a specific week (week 19). This falls directly under the definition of 'Transaction in Own Shares' (POS), which covers reports of a company buying back its own shares.
2020-05-11 Danish
Coloplast A/S - Transactions in connection with share buy-back programme, week 19
Regulatory Filings
2020-05-11 English
Coloplast A/S - Transactions in connection with share buy-back programme, week 19
Transaction in Own Shares Classification · 100% confidence The document is a formal announcement detailing specific transactions related to a share buy-back programme, including a table of daily share purchases, average prices, and total transaction values. This aligns perfectly with the definition for 'Transaction in Own Shares' (POS), which covers reports of a company buying back its own shares.
2020-05-11 English
Transaction in Own Shares 2020
Transaction in Own Shares Classification · 100% confidence The document title explicitly states "Transactions in connection with share buy-back programme, week 19". The content details specific dates (4 – 7 May 2020), the number of shares transacted, average purchase prices, and the accumulated value under the buyback program. This directly corresponds to the definition of a company reporting on its own share repurchase activities. This matches the 'Transaction in Own Shares' category (POS).
2020-05-11 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.